Bionova Scientific will present practical strategies for moving complex biologics from initial screening to a GMP-ready purification process at BioProcess International 2026.
Published
Signal category
Presence & Recognition
Quote
“At BioProcess International 2026, Bionova Scientific’s Samuel Claesson, M.E., Associate Scientist, Downstream Process Development, will share practical strategies for moving complex biologics from initial screening to a GMP-ready purification process.”
— Bionova Scientific team
Company
Bionova Scientific
CDMO Services (Research, Development and cGMP Manufacturing for Biologics)
- Industry
- Biotechnology Research
- Location
- Fremont, US
- Company size
- 147 employees
Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova’s renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early stage research material generation to Process Development and GMP manufacturing, Bionova’s teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients.
Founded 2014